A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
NCT05252585
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
4
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Angiomyolipoma
Interventions
DRUG:
Everolimus
Sponsor
Novartis Pharmaceuticals